These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 5879946)

  • 21. Hidden phosphorus in popular beverages.
    Murphy-Gutekunst L
    Nephrol Nurs J; 2005; 32(4):443-5. PubMed ID: 16180787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evolution in vitamin D treatment after debut of sevelamer hydrochloride in chronic renal failure patients].
    Suzuki M
    Clin Calcium; 2004 Sep; 14(9):60-3. PubMed ID: 15577112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normocalcemic primary hyperparathyroidism: resistance to PTH effect on tubular reabsorption of calcium.
    Gardin JP; Paillard M
    Miner Electrolyte Metab; 1984; 10(5):301-8. PubMed ID: 6493158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes in calcium metabolism after parathyroidectomy in primary hyperparathyroidism].
    Berczi C; Balogh A; Balázs G; Lukács G
    Orv Hetil; 2002 Mar; 143(12):597-600. PubMed ID: 11963396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function: what are the implications?
    Wang AY; Woo J; Sea MM; Law MC; Lui SF; Li PK
    Am J Kidney Dis; 2004 Apr; 43(4):712-20. PubMed ID: 15042549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Phospho-calcic disorders during secondary bone cancers of osteolytic form].
    Ryckewaert A; de Sèze S; Lanham C; Hioco D; Miravet L; Bieder C
    Pathol Biol; 1965 Dec; 13(23):1180-7. PubMed ID: 5323276
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hypophosphoremia in intensive care].
    Fourrier F
    LARC Med; 1983; 3(7):481-2, 484. PubMed ID: 6645738
    [No Abstract]   [Full Text] [Related]  

  • 28. Association of disorders in mineral metabolism with progression of chronic kidney disease.
    Schwarz S; Trivedi BK; Kalantar-Zadeh K; Kovesdy CP
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):825-31. PubMed ID: 17699293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-existence of X-linked hypophosphatemic rickets (XLH) and primary hyperparathyroidism: case report and review of the literature.
    Tournis ST; Giannikou PV; Paspati IN; Katsalira EA; Voskaki IC; Lyritis GP
    J Musculoskelet Neuronal Interact; 2005 Jun; 5(2):150-4. PubMed ID: 15951631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biological diagnosis--postoperative outcome in 25 cases of primary hyperparathyroidism].
    Calvet JP; Bordier P; Miravet L; Hioco D
    Ann R Coll Surg Engl; 1966 Sep; 39(3):142-5. PubMed ID: 5919241
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of brain death and non-heart-beating kidney donation on renal function and injury: an assessment in the isolated perfused rat kidney.
    van den Eijnden MM; Leuvenink HG; Ottens PJ; 't Hart NA; van Oeveren W; Morariu AM; van Goor H; Ploeg RJ
    Exp Clin Transplant; 2003 Dec; 1(2):85-95. PubMed ID: 15859914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disorders of calcium and phosphorus metabolism after successful kidney transplantation.
    Ulmann A; Chkoff N; Lacour B
    Adv Nephrol Necker Hosp; 1983; 12():331-40. PubMed ID: 6404142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphate metabolism in the setting of chronic kidney disease: significance and recommendations for treatment.
    Kestenbaum B
    Semin Dial; 2007; 20(4):286-94. PubMed ID: 17635817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Up-regulation of Cbfa1 and Pit-1 in calcified artery of uraemic rats with severe hyperphosphataemia and secondary hyperparathyroidism.
    Mizobuchi M; Ogata H; Hatamura I; Koiwa F; Saji F; Shiizaki K; Negi S; Kinugasa E; Ooshima A; Koshikawa S; Akizawa T
    Nephrol Dial Transplant; 2006 Apr; 21(4):911-6. PubMed ID: 16384827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Medical-surgical integrated approach in the treatment of non-paraneoplasic hyperparathyroidism: our experience].
    Pulvirenti D; Aikaterini T; Campagna A; Ignaccolo L; Giustolisi N; Costa E
    Clin Ter; 2008; 159(5):307-10. PubMed ID: 18998031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Defining the role of sevelamer chloride as a therapeutic agent for management of phosphate in patient with hemodialysis].
    Hashimoto N; Miyata M; Sato N; Mochizuki T; Koike T
    Clin Calcium; 2005 Sep; 15 Suppl 1():30-4; discussion 34. PubMed ID: 16272626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperphosphatemia and tumor lysis syndrome.
    Koduri PR
    Ann Hematol; 2005 Oct; 84(10):696. PubMed ID: 15999283
    [No Abstract]   [Full Text] [Related]  

  • 38. [ON A CASE OF PRIMARY HYPERPARATHYROIDISM].
    CRIVETZ D; ILCA S
    Med Interna (Bucur); 1963 Nov; 15():1385-91. PubMed ID: 14094454
    [No Abstract]   [Full Text] [Related]  

  • 39. [The intensity of restoration of macroergic phosphorus compounds in different functional states of the thyroid gland].
    L'vovich NA; Turakulov IaKh
    Probl Endokrinol Gormonoter; 1965; 11(3):64-8. PubMed ID: 5865981
    [No Abstract]   [Full Text] [Related]  

  • 40. [On the toxic factor during a shock].
    Petrov M; Milev M
    Lyon Chir; 1968; 64(6):933-5. PubMed ID: 5713503
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.